| |
| |
|
| Insider
Information: |
Allan Jonathan |
| Relationship: |
|
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
31,565 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$358,263 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,565 |
|
|
| Total
Value |
$358,263 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stoke Therapeutics, Inc. |
STOK |
|
2025-03-19 |
31,565 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2025-03-19 |
4 |
S |
$8.27 |
$16,085 |
D/D |
(1,945) |
31,565 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2025-03-18 |
4 |
S |
$8.67 |
$19,646 |
D/D |
(2,266) |
33,510 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2025-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,475 |
35,776 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-12-09 |
4 |
AS |
$12.99 |
$185,978 |
D/D |
(13,666) |
21,476 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-12-06 |
4 |
S |
$12.78 |
$123,891 |
D/D |
(9,696) |
35,142 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
44,838 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,927 |
38,838 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-05-20 |
4 |
AS |
$15.04 |
$129,327 |
D/D |
(8,599) |
2,598 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-05-20 |
4 |
OE |
$7.07 |
$60,795 |
D/D |
8,599 |
11,197 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-03-28 |
4 |
AS |
$13.19 |
$67,668 |
D/D |
(5,126) |
2,598 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-03-19 |
4 |
S |
$6.10 |
$14,326 |
D/D |
(2,349) |
7,724 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
GENERAL COUNSEL & CORP SEC |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,475 |
10,073 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
General Counsel & Corp Sec |
• – – |
2023-06-21 |
4 |
AS |
$13.48 |
$26,252 |
D/D |
(1,948) |
0 |
0 |
% |
|
| STOK |
Stoke Therapeutics, Inc. |
General Counsel & Corp SecOffi |
• – – |
2023-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,948 |
|
% |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
